RevolutionEHR introduced RevPay, an embedded payments solution that integrates checkout, patient records, and reporting within its AI‑native platform. The tool supports card, ACH, digital wallets and offers optional patient surcharging, promising to reduce processing fees that can cost $10,000‑$18,000 annually for a $1 million practice. By providing real‑time transaction dashboards and automatic ledger mapping, RevPay aims to streamline revenue collection and free staff for patient care. The launch positions RevolutionEHR as a comprehensive financial and clinical workflow hub for optometry practices.
Median Technologies announced it will present at TD Cowen’s 46th Annual Health Care Conference in Boston from March 2‑4, 2026. CEO Fredrik Brag will discuss the company’s latest AI‑driven SaMD developments and upcoming milestones on March 4 at 11:10 am ET. The presentation will be...
CFG Health launched CareLink, a proprietary 24/7 telehealth platform designed for correctional facilities. Built on existing security‑issued tablets, the solution delivers emergency triage, primary, behavioral, and specialty care while maintaining HIPAA compliance. The platform combines CFG’s in‑house clinicians with external...
Acupath Laboratories has partnered with Azer Scientific to install the first AzerView LH510 digital pathology scanner in the United States. The LH510 offers high‑resolution whole‑slide imaging and streamlined workflow features designed for clinical, academic, and reference labs. The installation marks...
Cowellnex Co., Ltd. and Metagen, Inc. will begin joint research in February 2026 to create new gut‑microbiota test items and a personalized food‑recommendation algorithm using Cowellnex’s three‑year shotgun metagenomic dataset. The partnership leverages Cowellnex’s high‑precision Japanese microbiome data and Metagen’s...
Weave (NYSE: WEAV), the AI‑driven patient engagement SaaS provider, announced it will present at the Raymond James 47th Annual Institutional Investors Conference on March 2, 2026 in Orlando. CEO Brett White and CFO Jason Christiansen will lead a fireside‑chat at 4:35 pm ET, followed by...
Sun Nuclear launched its 15th QA & Dosimetry Symposium (QADS) in Rome, gathering more than 230 clinical physicists from nearly 40 countries. The event introduced the Daily QA 4 Pro, a combined dosimetry‑imaging device designed to streamline daily machine quality checks. Demonstrations also...

Sibel Health and LookDeep Health announced a strategic partnership that merges Sibel’s FDA‑cleared ANNE® One wearable, which continuously captures clinical‑grade vitals, with LookDeep’s aimee™ bedside AI that adds real‑time visual and audio context. The combined platform targets emergency departments, general...
Mevion Medical Systems announced that its S250‑FIT proton therapy system has received CE marking under EU MDR, allowing marketing and clinical use across the European Union. The compact, LINAC‑vault‑ready platform, already cleared by the U.S. FDA, fits into standard radiation...
Galderma announced that regulatory agencies in the European Union, United States and Canada have approved a new state‑of‑the‑art Restylane® syringe for use with its NASHA® lidocaine filler line. The device is cleared for a broad set of facial areas—including cheeks,...
HekaBio K.K. and Alpha Tau Medical have secured Japanese regulatory approval for Alpha DaRT, a diffusing alpha‑radiation therapy for unresectable locally advanced or recurrent head‑and‑neck cancer. The approval makes Japan the first country outside Israel to clear the device, positioning HekaBio...
Natera reported Phase 2 SINERGY trial results showing a 63% objective response rate in recurrent or metastatic head and neck squamous cell carcinoma when treatment was adapted using Signatera circulating tumor DNA monitoring. Seventy‑four percent of the 27 patients were de‑escalated...
Epredia and Mindpeak have signed a distribution agreement to bring Mindpeak’s AI‑driven image‑recognition software to Epredia’s European digital pathology customers. The AI modules deliver pixel‑level analysis for breast, lung, gastrointestinal cancers and biomarker quantification, operating without cloud connectivity to preserve...
Ambience Healthcare was named the 2026 KLAS/CHIME Trailblazer Award winner, recognizing its leadership in AI‑driven clinical documentation and revenue integrity. The award, now in its second year, evaluates vendors on KLAS performance scores, client feedback, and measurable industry impact. Ambience’s...
Flatiron Health showcased its global Prostate and Bladder Cancer Panoramic datasets at the ASCO GU 2026 symposium, leveraging over 420,000 longitudinal patient records from the US, UK and Germany. Six research presentations highlighted critical gaps in genetic testing, equitable access...
Exact Sciences Corp announced that over 99% of voting shares, representing about 67% of outstanding shares as of the Jan 9, 2026 record date, approved Abbott's proposed acquisition. The deal will pay $105 cash per share and is expected to close by...